DI TARANTO, MARIA DONATA
 Distribuzione geografica
Continente #
NA - Nord America 1.103
EU - Europa 591
AS - Asia 237
AF - Africa 38
Totale 1.969
Nazione #
US - Stati Uniti d'America 1.062
IT - Italia 311
CN - Cina 118
NL - Olanda 85
SG - Singapore 74
DE - Germania 43
IE - Irlanda 40
CA - Canada 38
CI - Costa d'Avorio 38
FI - Finlandia 36
VN - Vietnam 26
SE - Svezia 20
UA - Ucraina 11
GB - Regno Unito 10
RO - Romania 10
IN - India 9
FR - Francia 7
HK - Hong Kong 7
BE - Belgio 3
BG - Bulgaria 3
MX - Messico 3
CH - Svizzera 2
CZ - Repubblica Ceca 2
RU - Federazione Russa 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
HR - Croazia 1
IR - Iran 1
LT - Lituania 1
MT - Malta 1
SA - Arabia Saudita 1
Totale 1.969
Città #
Chandler 223
Ashburn 94
Amsterdam 84
Napoli 67
Millbury 66
Naples 57
Singapore 51
Boardman 44
Princeton 41
Boston 37
Nanjing 37
Des Moines 32
Ottawa 31
Beijing 30
Lawrence 27
Dong Ket 26
Wilmington 17
Jacksonville 14
Washington 14
Nanchang 13
Woodbridge 13
Augusta 10
Los Angeles 10
Milan 10
Redwood City 10
Rome 10
Timisoara 10
Dublin 9
Norwalk 9
Shenyang 9
Cercola 7
Hebei 7
Seattle 7
Tianjin 6
Kronberg 5
Marsala 5
Rimini 5
Central 4
Forlì 4
Formia 4
Hangzhou 4
Mariglianella 4
Santa Maria Capua Vetere 4
Brussels 3
Caserta 3
Houston 3
Nocera Superiore 3
Redmond 3
San Mateo 3
Sofia 3
Toronto 3
Alcamo 2
Bratislava 2
Casal di Principe 2
Changchun 2
Changsha 2
Chicago 2
Delhi 2
Florence 2
Hanover 2
Jiaxing 2
Kunming 2
Lanzhou 2
Lappeenranta 2
Leawood 2
Mexico 2
Monreale 2
Mountain View 2
New York 2
Palermo 2
Sham Shui Po 2
Torre Del Greco 2
Afragola 1
Arzano 1
Bacoli 1
Brusciano 1
Casalnuovo Di Napoli 1
Casoria 1
Cava de' Tirreni 1
Cellole 1
Coimbatore 1
Cologne 1
Dallas 1
Denver 1
Dubai 1
Duncan 1
Ercolano 1
Fairfield 1
Falls Church 1
Fontainebleau 1
Fredericktown 1
Geneva 1
Giba 1
Giugliano In Campania 1
Gragnano 1
Helsinki 1
Hong Kong 1
Indiana 1
Marsico Nuovo 1
Monmouth Junction 1
Totale 1.265
Nome #
Galectin-3 and Lp(a) plasma concentrations and advanced carotid atherosclerotic plaques: correlation with plaque presence and features 92
Cerebrotendinous xanthomatosis, a metabolic disease with different neurological signs: two case reports 48
A case of cerebrotendinous xanthomatosis in a woman with a normal cholesterolemia. 47
EXPRESSION OF ADIPONECTIN RECEPTORS IN HUMAN CAROTID ATHEROSCLEROTIC PLAQUES Abstracts from the 12th National Congress of the Italian Society of Cardiovascular Prevention (SIPREC), Naples, 6–8 March 2014 47
C-reactive protein levels are associated with paraoxonase polymorphism L55M in patients undergoing cardiac SPECT imaging 46
Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia 46
Identification and functional characterization of LDLR mutations in familial hypercholesterolemia patients from Southern Italy 42
A wide next-generation-sequencing panel improves the molecular diagnosis of dyslipidemias 41
Carotid Endarterectomy versus Carotid Artery Stenting with Double-Layer Micromesh Carotid Stent: contemporary results of a single-center retrospective study 39
Association of USF1 and APOA5 polymorphisms with familial combined hyperlipidemia in an Italian population. 38
Polymorphisms and the expression of genes encoding enzymes involved in cardiovascular diseases 37
Identification of deletions in LDLR gene by Multiplex Ligation-Dependent Probe Amplification Analysis. 36
Familial hypercholesterolemia: A complex genetic disease with variable phenotypes 36
Genetic Heterogeneity of Familial Hypercholesterolemia: Repercussions for Molecular Diagnosis 35
Decreased Paraoxonase-2 Expression in Human Carotids During the Progression of Atherosclerosis 35
Homocysteine levels and sustained virological response to pegylated-interferon alpha2b plus ribavirin therapy for chronic hepatitis C: a prospective study. 34
Identificazione e caratterizzazione funzionale di mutazioni nel gene LDLR in pazienti del sud Italia affetti da Ipercolesterolemia familiare. 34
Investigation of Single Nucleotide Polymorphisms Associated to Familial Combined Hyperlipidemia with Random Forests. 34
The role of galectin-3 and LP(A) in atherosclerosis: A combined analysis of serum levels and plaque characteristics 34
Endovascular Treatment Versus Medical Therapy for Hypertensive Patients with Renal Artery Stenosis: An Updated Systematic Review 34
Age-related changes of cholestanol and lathosterol plasma concentrations: An explorative study 34
Correlation between low adenosine A2A receptor expression and hypercholesterolemia: A new component of the cardiovascular risk? 34
Lipid profile and genetic status in a familial hypercholesterolemia pediatric population: exploring the LDL/HDL ratio 33
Identification of deletions in LDRR gene by multiplex ligation-dependent probe amplification analysis 32
A case of cerebrotendinous xantomatosis in a woman with a normal colesterolemia 32
Expression of inflammation-related genes in human atherosclerotic plaques. 32
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 32
Functional characterization of mutant genes associated with autosomal dominant familial hypercholesterolemia: Integration and evolution of genetic diagnosis 32
Genetic spectrum of familial hypercholesterolemia and correlations with clinical expression: Implications for diagnosis improvement 32
Expression of inflammation-related genes in human atherosclerotic plaque. 31
Lipoprotein (a) is an independent predictor of cardiovascular events in Mediterranean women (Progetto Atena) 31
Association between causative mutations and response to PCSK9 inhibitor therapy in subjects with familial hypercholesterolemia: A single center real-world study 31
A first comparative study on two cell colture techniques – stimulated T cells and continous lymphoblastoid cell lines – in the detection of LDL receptor residual activity versus molecular genetic analysys 30
Altered expression of inflammation-related genes in human carotid atherosclerotic plaques. 30
Identification and functional characterization of a new mutation leading to defective uptake of LDL-LDLR complex. 29
Characterization of two novel pathogenic variants at compound heterozygous status in lipase maturation factor 1 gene causing severe hypertriglyceridemia 29
Targeting Nanostrategies for Imaging of Atherosclerosis 29
Familial Combined Hyperlipidemia: identification of misdiagnosed patients by detection of LDLR mutations. 28
Familial hypercholesterolemia: a flow chart for the molecular diagnosis. 28
Relazione tra polimorfismi del gene paraoxonasi ed ischemia miocardica indotta da stress in pazienti con sospetta malattia coronarica 28
An improved method on stimulated T-lymphocytes to functionally characterize novel and known LDLR mutations. 28
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 28
The Arg499His gain-of-function mutation in the C-terminal domain of PCSK9 28
A Real-World Experience of Clinical, Biochemical and Genetic Assessment of Patients with Homozygous Familial Hypercholesterolemia 28
Advances in Computational Methods for Genetic Diseases 26
A case of Cerebrotendinous Xanthomatosis with spinal cord involvement and without tendon xanthomas: identification of a new mutation of the CYP27A1 gene 26
The role of immunosuppressive therapy in aneurysmal degeneration of hemodialysis fistulas in renal transplant patients: Aneurysmatic arteriovenous fistula in transplant patients 26
Identification of Single Nucleotide Polymorphisms associated to Familial Combined Hyperlipidemia. 25
Changes in carotid stiffness in patients with familial hypercholesterolemia treated with Evolocumab®: A prospective cohort study 25
The novel variant p.Ser465Leu in the PCSK9 gene does not account for the decreased LDLR activity in members of a FH family 24
Identification and in vitro characterization of two new PCSK9 Gain of Function variants found in patients with Familial Hypercholesterolemia 23
Association between Inguinal Hernia and Arterial Disease: A Preliminary Report 23
Endothelial function improvement in patients with familial hypercholesterolemia receiving PCSK-9 inhibitors on top of maximally tolerated lipid lowering therapy 22
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 21
Clinical and Pathological Correlations in Chronic Venous Disease 21
Calprotectin Levels and Neutrophil Count Are Prognostic Markers of Mortality in COVID-19 Patients 20
Valutazione di parametri di ossidazione in placche aterosclerotiche e plasma di pazienti endoarteriectomizzati. 19
SMALL DENSE LDL IN RELATION TO CHANGES IN OXIDATION MARKERS AND VASCULAR REACTIVITYIN PATIENTS WITH HYPERCHOLESTEROLEMIA TREATED WITH EVOLOCUMAB: A PROSPECTIVE COHORT STUDY 18
ECHOCARDIOGRAFIC ANDECO-DOPPLER ABNORMALITIESIN RELATION TO LDL CHOLESTEROLIN FAMILIAL HYPERCHOLESTEROLEMIA 17
Identification of single nucleotide polymorphisms associated to familial combined hyperlipidemia 16
Molecular diagnosis of Familial Hypercholesterolemia: the utility of a country specific protocol. 16
MANAGEMENT OF SEVEREHYPERCHOLESTEROLEMIA IN A FAMILYBEARING C.974G>A LDL RECEPTORMUTATION 16
IDENTIFICATION AND FUNCTIONALCHARACTERIZATION OF A NEW MUTATIONLEADING TO DEFECTIVE UPTAKEOF LDL-LDLR COMPLEX 16
IDENTIFICATION OF LDLR MUTATIONSIN PATIENTS WITH FAMILIAL COMBINEDHYPERLIPIDEMIA 15
The Impact of Chronic Kidney Disease on Peripheral Artery Disease and Peripheral Revascularization 14
Harnessing the potential of metalloproteinases in extracellular vesicles: a window of opportunity for aneurysm management 14
Metalloproteinases between History, Health, Disease, and the Complex Dimension of Social Determinants of Health 13
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia 13
Studio del miRNome e caratterizzazione funzionale del LDLR per l’identificazione di nuove cause molecolari dell’ipercolesterolemia familiare [miRNome study and functional characterization of LDLR for the identification of new molecular causes of Familial Hypercholesterolemia] 11
Statistical and Computational Methods for Genetic Diseases: An Overview 9
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study 7
Multiparametric platform for profiling lipid trafficking in human leukocytes 7
The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group 6
Galectin-3 in cardiovascular diseases 6
Changes in markers of subclinical atherosclerosis in patients with familial hypercholesterolemia treated with evolocumab: a prospective cohort study 4
Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group 4
Impact of 12-SNP and 6-SNP Polygenic Scores on Predisposition to High LDL-Cholesterol Levels in Patients with Familial Hypercholesterolemia 4
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 3
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 3
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 2
Simplified Criteria for Identification of Familial Hypercholesterolemia in Children: Application in Real Life 2
Changes in markers of subclinical atherosclerosis in patients with familial hypercholesterolemia treated with evolocumab: a prospective cohort study 2
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 1
Totale 2.104
Categoria #
all - tutte 9.184
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.184


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 0 1
2019/2020208 61 1 8 4 13 11 23 14 5 20 31 17
2020/2021204 8 13 26 8 16 23 6 13 14 10 31 36
2021/2022423 21 5 2 14 14 22 7 17 32 15 116 158
2022/2023573 72 23 24 26 91 70 3 57 87 85 29 6
2023/2024487 30 69 40 35 28 49 12 70 4 20 76 54
Totale 2.104